PRESS RELEASE published on 08/22/2024 at 12:44, 2 months 30 days ago Successful VAT reclaim of £12.2 million Novacyt successfully reclaims £12.2 million in VAT from HMRC, increasing net cash position by over £7.0 million. Inside information disclosed Inside Information Novacyt VAT Reclaim Net Cash Position HMRC
BRIEF published on 07/25/2024 at 12:32, 3 months 27 days ago Novacyt publishes its unaudited half-yearly activity report Acquisition R&D Turnover Novacyt Semestrial Report
BRIEF published on 07/25/2024 at 12:29, 3 months 27 days ago Novacyt Announces Half Year Trading Update for 2024 Revenue Growth Strategic Initiatives Regulatory Approvals Financial Update New Products
PRESS RELEASE published on 07/25/2024 at 12:24, 3 months 27 days ago Half Year Trading Update Novacyt S.A. announces unaudited trading update for H1 2024, showcasing revenue growth, cash position, cost-saving measures, and strategic progress across clinical, instrumentation, and R&D segments Revenue Growth Trading Update Cost-saving Measures Novacyt S.A. R&D Progress
BRIEF published on 07/22/2024 at 12:42, 3 months 30 days ago Results of the Novacyt Annual General Meeting Nomination Resolutions General Assembly Molecular Diagnostics Novacyt
BRIEF published on 07/22/2024 at 12:41, 3 months 30 days ago Novacyt Announces AGM Results and New Board Appointments AGM Executive Directors Molecular Diagnostics Board Appointments Novacyt
PRESS RELEASE published on 07/22/2024 at 12:36, 3 months 30 days ago Result of AGM Novacyt S.A. announces successful AGM with new Executive Directors. Visit the company's website for AGM voting results Voting Results AGM Executive Directors Molecular Diagnostics Novacyt
BRIEF published on 07/18/2024 at 12:40, 4 months 3 days ago Novacyt announces the financial impacts of the agreement with DHSC Treasury VAT Financial Agreement Novacyt DHSC
BRIEF published on 07/18/2024 at 12:38, 4 months 3 days ago Novacyt Announces Financial Impact of DHSC Settlement Financial Impact Novacyt DHSC Settlement VAT Reclaim Clinical Diagnostics
PRESS RELEASE published on 07/18/2024 at 12:33, 4 months 3 days ago AGM Statement on Impact of DHSC Settlement Novacyt provides update on AGM statement regarding DHSC settlement impact, anticipating a potential £7m net cash increase from VAT reclaim. Details of income statement and cash flow implications disclosed Novacyt DHSC Settlement VAT Reclaim AGM Statement Net Cash Increase
Published on 11/21/2024 at 22:05, 1 hour 24 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 1 hour 39 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 3 hours 14 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 3 hours 19 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 20:00, 3 hours 29 minutes ago Victory for New York Homeowners: Petroff Amshen LLP Blocks Lender’s Repeated Foreclosure Attempt
Published on 11/21/2024 at 19:01, 4 hours 27 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 4 hours 52 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 5 hours 30 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 5 hours 37 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 5 hours 37 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 16 hours 31 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 4 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 5 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 5 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 15 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
